emotive is a global healthcare communications agency. After achieving consistent growth in 2018, we entered 2019 wanting to differentiate ourselves and adapt our business to the changing needs of our clients. Having gained experience in novel therapies, we decided to make this our focus and position the business to service biopharma targeting rare disorders and those with exciting advanced therapies. We set up an Advanced Therapies Unit and increased our expertise through talent acquisition. To offer a wider suite of services for our global clients, we formed a group with two consultancies offering insight and access and opened a US office. Over 18 months we won 14 new accounts and exceeded our growth targets.
We supported clients with a range of novel therapies and achieved an average score of 5.68 out of 6 in our client satisfaction survey. We won Gold at the PM Society Digital Awards for our ‘Spot the Rare’ campaign and won Pharma Times Communications Team of the Year Award in the Charity Category. We invested heavily in team training and culture and maintained morale even during lockdown. We also made 14 new hires and improved retention.
emotive had impressive business growth and strong geographic expansion. The strategy and positioning is good and well aligned. They have a comprehensive plan, with great client testimonials. Their talent growth is good and the approach is very well-rounded and beyond simply a business plan.
Entry deadline | 26 August 2022 |
Extended entry deadline | 2 September 2022* *additional fee applies |
Judging Day | 6 October 2022 |
Company/Team of the Year Interviews | 21 October 2022 |
PMEA Event | 23 November 2022 |